HER2 positive cancers

Related by string. * Her2 : HER2 positive breast cancer . HER2 positive . HER2 positivity . HER2 negative . HER2 positive metastatic breast / Positives . POSITIVE . positives . POSITIVES : Rating Watch Positive . estrogen receptor positive . retrieve false positives . tested positive / CANCERS . Cancers : Gastrointestinal Cancers Symposium . skin cancers . colon cancers . bile duct cancers * *

Related by context. Frequent words. (Click for all words.) 68 breast carcinoma 68 endometrial cancers 67 malignant pleural mesothelioma 67 heavily pretreated 67 epithelial ovarian cancer 67 HER2 negative 67 KRAS wild 66 EGFR mutation 66 xenograft models 66 estrogen receptor ER 66 adenocarcinomas 66 EGFR mutations 66 ovarian breast 66 carcinoid 65 neoadjuvant chemotherapy 65 KRAS mutations 65 carcinoid tumors 65 estrogen receptor negative 65 heavily pretreated patients 65 distant metastasis 64 pheochromocytoma 64 recurrent ovarian cancer 64 metastatic lesions 64 neoadjuvant therapy 64 bone metastasis 64 neoplasm 64 HER2 positive metastatic breast 63 HER2 positive 63 grade gliomas 63 distant metastases 63 colorectal tumors 63 glioblastoma multiforme GBM 63 micrometastases 63 neoadjuvant 63 cabazitaxel 63 coinfected 63 gastric cancers 63 lymph node involvement 62 pertuzumab 62 lymph node metastases 62 colorectal cancer CRC 62 metastatic renal cell carcinoma 62 lung adenocarcinoma 62 HPV# 62 hepatocellular carcinoma HCC 62 PCa 62 mRCC 62 malignant lesions 62 brain metastases 62 superficial bladder cancer 62 squamous cell 62 poorer prognosis 62 medullary thyroid cancer 62 BRAF mutation 62 BRCA mutations 61 elevated CRP 61 lymphomas 61 BRCA2 mutations 61 neuroendocrine tumors 61 pancreatic cancers 61 bladder cancers 61 biochemical recurrence 61 myeloproliferative disorders 61 BRCA1 mutations 61 chemoradiotherapy 61 androgen independent 61 IGFBP 3 61 mycophenolate mofetil 61 serum PSA 61 epithelial cancers 61 EGFR inhibitors 61 FLT3 61 lung metastases 61 oropharyngeal cancer 61 metastatic liver 61 pazopanib 61 premalignant 61 systemic lupus erythematosus SLE 61 androgen deprivation 61 estrogen receptor positive 61 gastrointestinal cancers 60 adjuvant therapy 60 % CI #.#-#.# [007] 60 ependymoma 60 XELOX 60 myeloid leukemia 60 lung nodules 60 PlGF 60 PARP inhibitor 60 eribulin 60 infarcts 60 WT1 60 gastrointestinal stromal tumors 60 anal cancers 60 uterine cancers 60 liver metastases 60 cardiac dysfunction 60 melanoma tumors 60 antigen PSA 60 confidence interval #.#-#.# 60 chlorambucil

Back to home page